首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.
【24h】

The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome.

机译:常性性腺功能减退性腺功能减退症和Kallmann综合征患者双基因突变的患病率。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine the prevalence of digenic mutations in patients with idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS). DESIGN: Molecular analysis of DNA in IHH/KS patients. SETTING: Academic medical center. PATIENT(S): Twenty-four IHH/KS patients with a known mutation (group 1) and 24 IHH/KS patients with no known mutation (group 2). INTERVENTION(S): DNA from IHH/KS patients was subjected to polymerase chain reaction-based DNA sequencing of the 13 most common genes (KAL1, GNRHR, FGFR1, KISS1R, TAC3, TACR3, FGF8, PROKR2, PROK2, CHD7, NELF, GNRH1, and WDR11). MAIN OUTCOME MEASURE(S): The identification of mutations absent in >/=188 ethnically matched controls. Both SIFT (sorting intolerant from tolerant) and conservation among orthologs provided supportive evidence for pathologic roles. RESULT(S): In group 1, 6 (25%) of 24 IHH/KS patients had a heterozygous mutation in a second gene, and in group 2, 13 (54.2%) of 24 had a mutation in at least one gene, but none had digenic mutations. In group 2, 7 (29.2%) of 24 had a mutation considered sufficient to cause the phenotype. CONCLUSION(S): When the 13 most common IHH/KS genes are studied, the overall prevalence of digenic gene mutations in IHH/KS was 12.5%. In addition, approximately 30% of patients without a known mutation had a mutation in a single gene. With the current state of knowledge, these findings suggest that most IHH/KS patients have a monogenic etiology.
机译:目的:确定特发性性腺功能减退性腺功能减退症(IHH)和卡尔曼综合征(KS)患者双基因突变的患病率。设计:IHH / KS患者的DNA分子分析。地点:学术医学中心。患者:24例具有已知突变的IHH / KS患者(第1组)和24例无已知突变的IHH / KS患者(第2组)。干预:对来自IHH / KS患者的DNA进行基于聚合酶链反应的13种最常见基因(KAL1,GNRHR,FGFR1,KISS1R,TAC3,TACR3,FGF8,PROKR2,PROK2,CHD7,NELF, GNRH1和WDR11)。主要观察指标:鉴定> / = 188个种族匹配的对照中不存在的突变。 SIFT(将不耐受与不耐受分类)和直系同源物之间的保守性都为病理作用提供了支持性证据。结果:在第1组中,有24名IHH / KS患者中有6名(25%)在第二个基因中发生了杂合突变,在第2组中,有24名IHH / KS患者中有13名(54.2%)中至少有一个基因发生了突变,但没有双基因突变。在第2组中,有24个突变中有7个(29.2%)具有足以引起该表型的突变。结论:当研究13个最常见的IHH / KS基因时,IHH / KS中双基因突变的总体患病率为12.5%。此外,大约30%没有已知突变的患者在单个基因中具有突变。以目前的知识水平,这些发现表明大多数IHH / KS患者具有单基因病因。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号